Desk›Healthcare› RPG Life Sciences Ltd
RPG Life Sciences Ltd
BSE 532983 · NSE RPGLIFE · ISIN INE105J01010 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹2,571.70
-0.99%
BSE close, 28 August 2026
₹4,253.34 cr
1.7 cr shares · Micro cap
₹1,101.53 cr
as published
35.6× · 11.21×
EPS ₹72.22 · BV ₹229.41
707.52 / 115.17
₹ cr, as filed
36
11 selected · 31%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -16.5% |
|---|---|
| Against 52-week low | +48.5% |
| Day change | -0.99% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹72.22 |
|---|---|
| Price / earnings | 35.61× |
| Price / book | 11.21× |
| Book value — derived, price ÷ P/B | ₹229.41 |
| Return on equity | 31.49% |
| Operating margin | 24.40% |
| Net margin | 15.62% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 31.48%
- ROE as published
- 31.49%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 195.69 | 30.57 | 18.49 | 24.40% | 15.62% |
| Mar-26 · Q | 176.89 | 29.90 | 18.08 | 26.19% | 16.90% |
| FY25-26 | 707.52 | 115.17 | 69.64 | 24.96% | 16.28% |
Quarter on quarter
- Revenue, quarter on quarter
- +10.6%
- Net profit, quarter on quarter
- +2.2%
- Operating margin, quarter on quarter
- -179 bps
Disclosure profile 36 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Press Release | 3 |
| Investor Presentation | 2 |
| Acquisition | 1 |
| Board Outcome | 1 |
| Change in Management | 1 |
| KMP | 1 |
| Restructuring | 1 |
| Results | 1 |
| Selected sub-total | 11 |
| Procedural | |
| General | 10 |
| Analyst / Investor Meet | 5 |
| Newspaper Publication | 3 |
| AGM / EGM | 2 |
| Board Meeting | 1 |
| Clarification | 1 |
| Compliance Certificate | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 25 |
| Total | 36 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
36 filings · 11 selected · busiest 2026-07-29 and 2026-09-02
Filing rhythm · the twelve most recent
2026-09-032026-10-08
SelectedProcedural
Filings
36 in the window · 15 earlier on record
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 September 2026 ·
Newspaper Publication
Newspaper advertisement in respect to Special window opened for lodgment of transfer and dematerialization request(s).
Company Update / Newspaper Publication View filing →
-
28 September 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Clarus Capital I, Others
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
25 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Update On Share Purchase Agreement
update on share purchase agreement dated July 29, 2026 with Actis Generics Private Limited
Company Update / General View filing →
-
24 September 2026 ·
Clarification For Volume Movement Letter
Clarification for Volume Movement Letter
Company Update / General View filing →
-
24 September 2026 ·
Clarification sought from RPG Life Sciences Ltd
The Exchange has sought clarification from RPG Life Sciences Ltd on September 24, 2026, with reference to Movement in Volume. The reply is awaited.
Company Update / Clarification
-
17 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Analysts/Institutional Investors Meet
Company Update / Analyst / Investor Meet View filing →
-
15 September 2026 ·
Update On Business Transfer Agreement By RPGAP
Update on completion of BTA execution by RPG Active Pharma Limited with Raghava Life Sciences Private Limited
Company Update / General View filing →
-
9 September 2026 ·
Update On Investment And Shareholder Agreement
update on Investment and Shareholders Agreement entered on July 29, 2026, subsidiary of the company allotted securities to the Investors.
Company Update / General View filing →
-
4 September 2026 ·
Outcome Of Investors Meet
Update on Analyst/Institutional call
Company Update / General View filing →
-
3 September 2026 ·
-
2 September 2026 ·
-
2 September 2026 ·
Analyst / Investor Meet - Intimation
Schedule of Investors Meet
Company Update / Analyst / Investor Meet View filing →
-
2 September 2026 ·
Press Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
2 September 2026 ·
Intimation Of Execution Of BTA By RPG Active Pharma Limited (WOS) With Raghava Life Sciences Private Limited
Intimation of execution of Business Transfer Agreement by RPG Active Pharma Limited (WOS) with Raghava Life Sciences Private Limited for Acquisition of API Business.
Company Update / General View filing →
-
2 September 2026 ·
-
1 September 2026 ·
-
25 August 2026 ·
Analyst / Investor Meet - Intimation
The Company has informed about the Schedule of Analyst/Institutional Investors Meet
Company Update / Analyst / Investor Meet View filing →
-
20 August 2026 ·
Analyst / Investor Meet - Intimation
The Company has informed about the Schedule of Analyst/Institutional Investors Meet
Company Update / Analyst / Investor Meet View filing →
-
10 August 2026 ·
Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of the Analyst/Institutional ....
Company Update / Analyst / Investor Meet View filing →
-
31 July 2026 ·
Change in Management
Intimation on superannuation of Senior Management Personnel
Company Update / Change in Management View filing →
-
31 July 2026 ·
Newspaper Publication
Newspaper advertisement in respect to Special window opened for lodgement of transfer and dematerialization request(s).
Company Update / Newspaper Publication View filing →
-
29 July 2026 ·
Press Release / Media Release
Press Release
Company Update / Press Release / Media Release View filing →
-
29 July 2026 ·
-
29 July 2026 ·
-
29 July 2026 ·
Outcome Of Board Meeting Held Today July 29, 2026
Outcome of Board Meeting held today July 29, 2026
Company Update / General View filing →
-
29 July 2026 ·
Newspaper Publication
Copy of Newspaper Publication
Company Update / Newspaper Publication View filing →
-
28 July 2026 ·
-
28 July 2026 ·
Press Release / Media Release
Press release
Company Update / Press Release / Media Release View filing →
-
28 July 2026 ·
Unaudited Financial Results For The Quarter Ended June 30, 2026
Unaudited consolidated and standalone Financial Results for quarter ended June 2026
Result / Financial Results View filing →
-
28 July 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board meeting
Board Meeting / Outcome of Board Meeting View filing →
-
27 July 2026 ·
-
23 July 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results along with a copy of Scrutinizer's Report
AGM/EGM / AGM View filing →
-
23 July 2026 ·
-
21 July 2026 ·
Board Meeting Intimation for Financial Result For Quarter Ended June 2026
RPG Life Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia, to consider and approve Pursuant to the provisions ....
Board Meeting / Board Meeting View filing →
RSS feed for RPG Life Sciences Ltd · the 50 most recent filings